Guanidinoacetate–creatine in secondary progressive multiple sclerosis: a case report

Acute secondary progressive multiple sclerosis (SPMS) is characterized by escalating neurological disability, with limited disease-modifying therapeutic options. A 48-year-old woman with acute SPMS being treated with interferon beta-1a and oral corticosteroids presented as a clinical outpatient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostojic, Sergej M., Ostojic, Jelena, Zanini, Dragana, Jezdimirovic, Tatjana, Stajer, Valdemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753084/
https://www.ncbi.nlm.nih.gov/pubmed/35000485
http://dx.doi.org/10.1177/03000605211073305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753084/
https://www.ncbi.nlm.nih.gov/pubmed/35000485
http://dx.doi.org/10.1177/03000605211073305

Ejemplares similares